Bon Natural Life Limited (BON) Stock Score, Valuation & Financial Research
Bon Natural Life Limited is in the Basic Materials sector and Chemicals - Specialty industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.
Quick answer for BON
Bon Natural Life Limited currently has a Wall Street Score of 23/100. The stored market price is $1.1. Its financial score is 19/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Bon Natural Life Limited does
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islan
BON financial snapshot
- Wall Street Score:
- 23/100
- Current price:
- $1.1
- Market capitalization:
- $6.7M
- Revenue:
- $42.5M
- Net income:
- $-1.6M
- Free cash flow:
- $-4.2M
- Cash:
- $6.3M
- Total debt:
- $12.3M
- EPS:
- -0.01
- Financial score:
- 19/100
- Valuation score:
- 0/100
- Revenue score:
- 40/100
What stands out
- Reported year-over-year revenue growth is +1.3%.
- Free cash flow is $-4.2M, showing cash burn in the current stored period.
- The balance sheet shows $6.3M of cash versus $12.3M of total debt, so leverage deserves attention.
- The current research record carries a corporate distress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 19/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research BON
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.